HK/China Healthcare Analyst (ex-Fosun Pharma)

Xinyao (Criss) Wang

Over 15 years' experience in both finance and healthcare, covering clinic operations, investment and equity research in both China and overseas.

Pre-IPO CANbridge Pharmaceuticals - Insights on Products, Pipeline and the Concerns

Eyebright Medical Technology (688050. CH) - A Good Company but The Valuation Is Too High

Imeik Technology Development (300896.CH) - The Valuation Bubble?

Battle Lines Drawn As BABA Builds Out First/Last-Mile Capacity; But Who Will Fund 75+ Bn CNY CapEx?

Thematic (Sector/Industry)

Hong kong Healthcare equipment and services / Thematic (Sector/Industry)

Shanghai Haohai Biological Tec (688366 CH)

<p>Cosmetic contact lenses, due to the roles of both myopia correction and makeup FMCG products, are loved by young, especially female consumers in China. The potential of this industry is also very large and worth the attention of investors. This insight mainly analyzed the market potential, the business, and related investment opportunities in this industry.</p>

Cosmetic contact lenses, due to the roles of both myopia correction and makeup FMCG products, are loved by young, especially female consumers in China. The potential of this industry is also very large and worth the attention of investors. This insight mainly analyzed the market potential, the business, and related investment opportunities in this industry.

Industry Report - Insights on China Cosmetic Contact Lens Market